Overexpression of hERG1 in resected esophageal squamous cell carcinomas: A marker for poor prognosis

Journal of Surgical Oncology

Volumn 97, Issue 1, 2008, Pages 57-62

  Ding, Xiang Wu ^a   Luo, He Sheng ^b   Lou, Bing ^a   Xu, Dong Qiang ^a   Gao, Shan ^a  

^a Xiangfan Central Hospital   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Esophageal cancer; Human ether go go related gene; Prognosis

Indexed keywords

MESSENGER RNA; POTASSIUM CHANNEL HERG; PROTEIN HERG1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; CANCER PATIENT; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POTASSIUM CHANNELS, VOLTAGE-GATED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 38149111935     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20891     Document Type: Conference Paper

References (32)

1. Liu JF, Wang QZ, Hou J: Surgical treatment for cancer of the oesophagus and gastric cardia in Hebei, China. Br J Surg 2004;91:90-98.
2. Camacho J: Ether à go-go potassium channels and cancer. Cancer Lett 2006;233:1-9.
3. Warmke JW, Ganetzky B: A family of potassium channel genes related to EAG in Drosophila and mammals. Proc Natl Acad Sci U S A 1994;91:3438-3442.
4. Bauer CK, Schwarz JR: Physiology of EAG KC channels. J Membr Biol 2001;182:1-15.
5. Gutman GA, Chandy KG, Grissmer S, et al.: International Union of Pharmacology LIII Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 2005;57:473-508.
6. Lastraioli E, Taddei A, Messerini L, et al.: hERG1 channels in human esophagus: Evidence for their aberrant expression in the malignant progression of Barrett's esophagus. J Cell Physiol 2006;209:398-404.
7. Occhiodoro T, Bernheim L, Liu JH, et al.: Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett 1998;434:177-182.
8. +; channels. EMBO J 1999;18:5540-5547.
9. Bianchi L, Wible B, Arcangeli A, et al.: hERG encodes a KC current highly conserved in tumors of different histogenesis: A selective advantage for cancer cells? Cancer Res 1998;58:815-822.
10. Farias LM, Ocana DB, Diaz L, et al.: Ether à go-go potassium channels as human cervical cancer markers. Cancer Res 2004;64:6996-7001.
11. Cherubini A, Taddei GL, Crociani O, et al.: hERG1 potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium. Brit J Cancer 2000;83:1722-1729.
12. Lastraioli E, Guasti L, Crociani O, et al.: hERG1 gene and hERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res 2004;64:606-611.
13. Patt S, Preussat K, Beetz C, et al.: Expression of ether a go-go potassium channels in human gliomas. Neurosci Lett 2004;368:249-253.
14. Mello de Queiroz F, Suarez-Kurtz G, Stühmer W, et al.: Ether à go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer 2006;5:42.
15. Ding XW, Yan JJ, An P, et al.: Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines. World J Gastroenterol 2007;13:1257-1261.
16. Hemmerlein B, Weseloh RM, Mello de Queiroz F, et al.: Overexpression of EAG1 potassium channels in clinical tumours. Mol Cancer 2006;5:41.
17. Clark TG, Altman DG, De Stavola BL: Quantification of the completeness of follow-up. Lancet 2002;359:1309-1310.
18. Arcangeli A, Bianchi L, Becchetti A, et al.: A novel inwardrectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol 1995;489:455-471.
19. Arcangeli A, Rosati B, Cherubini A, et al.: hERG1- and IRK-like inward rectifier currents are sequentially expressed during neuronal development of neural crest cells and their derivatives. Eur J Neurosci 1997;9:2596-2604.
20. + channel in rat F-11 DRG cell line: Pharmacological identification and biophysical characterization. J Physiol 1996;496:13-23.
21. + channels in neoplastic hematopoietic cells. J Biol Chem 2002;277:18528-18534.
22. Biagiotti T, D'Amico M, Marzi I, et al.: Cell renewing in neuroblastoma: Electrophysiological and immunocytochemical characterization of stem cells and derivatives. Stem Cells 2006;24:443-453.
23. Pillozzi S, Brizzi MF, Balzi M, et al.: hERG1 potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 2002;16:1791-1798.
24. Crociani O, Guasti L, Balzi M, et al.: Cell cycledependent expression of hERG1 and hERG1B isoforms in tumor cells. J Biol Chem 2003;278:2947-2955.
25. Mega S, Miyamoto M, Ebihara Y, et al.: Cyclin D1, E2F1 expression levels are associated with characteristics and prognosis of esophageal squamous cell carcinoma. Dis Esophagus 2005;18:109-113.
26. Stoecklein NH, Siegmund A, Scheunemann P, et al.: Ep-CAM expression in squamous cell carcinoma of the esophagus: A potential therapeutic target and prognostic marker. BMC Cancer 2006;6:165.
27. Xue LY, Ren LQ, Luo W, et al.: Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma. Zhonghua Yi Xue Za Zhi 2003;87:150-154.
28. Uehara H, Miyamoto M, Kato K, et al.: Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma. J Surg Oncol 2005;92:109-115.
29. Wada S, Noguchi T, Takeno S, et al. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma. Ann Surg Oncol 2006;13:961-966.
30. Ishiyama A, Hibi K, Koike M, et al.: PTCH gene expression as a potential marker for esophageal squamous cell carcinoma. Anticancer Res 2006;26:195-198.
31. Takashima N, Ishiguro H, Kuwabara Y, et al.: Expression and prognostic roles of PABPC1 in esophageal cancer: Correlation with tumor progression and postoperative survival. Oncol Rep 2006;15:667-671.
32. Rosato A, Pivetta M, Parenti A, et al.: Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer 2006;119:1717-1722.